Edesa Biotech Valor de la empresa
¿Qué es el Valor de la empresa de Edesa Biotech?
El Valor de la empresa de Edesa Biotech, Inc. es $4.67M
¿Cuál es la definición de Valor de la empresa?
El valor empresarial es una medida del valor de mercado total de una empresa. Se calcula como capitalización de mercado con deuda, interés minoritario y acciones preferentes menos el efectivo total y equivalentes de efectivo.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor de la empresa de compañías en Sector Health Care en NASDAQ en comparadas con Edesa Biotech
¿Qué hace Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Empresas con valor de la empresa similar a Edesa Biotech
- Golden Ridge Resources tiene Valor de la empresa de $4.65M
- Accelerate Resources tiene Valor de la empresa de $4.65M
- Lodestar Minerals tiene Valor de la empresa de $4.66M
- RooLife Ltd tiene Valor de la empresa de $4.66M
- ABC India tiene Valor de la empresa de $4.66M
- Conico Ltd tiene Valor de la empresa de $4.66M
- Edesa Biotech tiene Valor de la empresa de $4.67M
- SiS Mobile tiene Valor de la empresa de $4.67M
- Tri-Star Resources Plc tiene Valor de la empresa de $4.67M
- HTC Purenergy tiene Valor de la empresa de $4.67M
- Prospect Park Capital tiene Valor de la empresa de $4.67M
- Spinnaker Acquisitions Plc tiene Valor de la empresa de $4.68M
- EZZ Life Science tiene Valor de la empresa de $4.68M